Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bergmann

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2023
Altered B-Cell Expansion and Maturation in Draining Mesenteric Lymph Nodes of Inflamed Gut in Crohn's DiseaseSonja Kappel-Latif, Prasanti Kotagiri, Lukas Schlager, et al.
Eclinicalmedicine|November 8, 2024
Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trialMaria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, et al.
Pharmacological Research|January 11, 2026
FASN targeting by G28UCM impairs mitochondrial fatty acid synthesis and reveals a FASN-SDHB Synthetic InteractionNastasia Wilfinger-Lutz, Kristina M Kuehrer, Maria J Bueno, et al.
JCI Insight|October 18, 2019
Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesisKarl Katholnig, Birgit Schütz, Stephanie D Fritsch, et al.
Plos One|June 23, 2009
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineJulia Romanova, Brigitte M Krenn, Markus Wolschek, et al.
Molecular Oncology|March 11, 2025
The atypical KRAS<sup>Q22K</sup> mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroidsTheresia Mair, Philip König, Milena Mijović, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal TumorsWei Zhang, Aurélie Auguste, Xiaoyun Liao, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid culturesJulijan Kabiljo, Anna Theophil, Jakob Homola, et al.
JAMA Network Open|August 22, 2025
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical TrialJohannes Laengle, Irene Kuehrer, Askin Kulu, et al.
The Journal of Infectious Diseases|December 31, 2009
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1Volker Wacheck, Andrej Egorov, Franz Groiss, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2023
Altered B-Cell Expansion and Maturation in Draining Mesenteric Lymph Nodes of Inflamed Gut in Crohn's DiseaseSonja Kappel-Latif, Prasanti Kotagiri, Lukas Schlager, et al.
Eclinicalmedicine|November 8, 2024
Efficacy and safety of asunercept, a CD95L-selective inhibitor, in hospitalised patients with moderate-to-severe COVID-19: ASUNCTIS, a multicentre, randomised, open-label, controlled, phase 2 trialMaria Pilar Ruiz Seco, José Ramón Paño Pardo, Christian Schoergenhofer, et al.
Pharmacological Research|January 11, 2026
FASN targeting by G28UCM impairs mitochondrial fatty acid synthesis and reveals a FASN-SDHB Synthetic InteractionNastasia Wilfinger-Lutz, Kristina M Kuehrer, Maria J Bueno, et al.
JCI Insight|October 18, 2019
Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesisKarl Katholnig, Birgit Schütz, Stephanie D Fritsch, et al.
Plos One|June 23, 2009
Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineJulia Romanova, Brigitte M Krenn, Markus Wolschek, et al.
Molecular Oncology|March 11, 2025
The atypical KRAS<sup>Q22K</sup> mutation directs TGF-β response towards partial epithelial-to-mesenchymal transition in patient-derived colorectal cancer tumoroidsTheresia Mair, Philip König, Milena Mijović, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal TumorsWei Zhang, Aurélie Auguste, Xiaoyun Liao, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid culturesJulijan Kabiljo, Anna Theophil, Jakob Homola, et al.
JAMA Network Open|August 22, 2025
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical TrialJohannes Laengle, Irene Kuehrer, Askin Kulu, et al.
The Journal of Infectious Diseases|December 31, 2009
A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1Volker Wacheck, Andrej Egorov, Franz Groiss, et al.
Pageof 15